Stock & Company Details
Galectin Therapeutics Inc $GALT
Price:
46,691,331
66M
$306M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
GALT technical indicators
Latest Galectin Therapeutics Inc (GALT) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
69.43 10.6%
MACD:
0.57 0.2%
SMA 50:
$2.67 1.6%
SMA 200:
$3.71 0.1%
EMA 20:
$3.48 2.6%
Bollinger Bands:
5.02 / 1.32
Stochastic:
80.96 10.6%
ADX 14:
41.33 1.3%
ATR 14:
0.39 0.5%
CCI 20:
110.03 25.4%
OBV:
10.55M 5.7%
ROC 12:
62.17% 20.1%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Finance Bot
Ask your questions
Start by typing a question below.
